> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Foundation Medicine Cancer Diagnostic Approved
- URL: https://www.fdaweb.com/foundation-medicine-cancer-diagnostic-approved/
- Published: 2018-03-30T12:00:00.000Z
- Updated: 2026-09-14T23:56:25.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5141113

FDA has approved Foundation Medicine’s FoundationOne CDx (F1CDx), a next generation sequencing-based *in vitro* diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type. The sponsor says that unlike other companion diagnostics, the F1CDx is a more extensive test that provides information on a number of different genetic mutations that may help in the clinical management of cancer patients. Also, based on individual test results, the new diagnostic reportedly can identify which patients with any of five tumor types may benefit from 15 different FDA-approved targeted treatment options.